We demonstrated that STAMBPL1 increased <i>HIF1A</i> transcription in a non-enzymatic manner, thereby activating the HIF1α/VEGFA signaling pathway to facilitate triple-negative breast cancer angiogenesis. The gene discussed is STAMBPL1; the disease is triple-negative breast carcinoma.